Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A case of fulminant neuromyelitis optica presenting with destructive lesions in whole-brain.
Demyelinating disease: Important role for KIR4.1 in demyelinating diseases.
Modeling the course and outcomes of MS is statistical twaddle-No.
Medical Tourism for CCSVI Procedures in People with Multiple Sclerosis: An Observational Study.
Misdiagnosis of Graves' disease with apparent severe hyperthyroidism in a patient taking biotin megadoses.
Neuro-immune interactions of neural stem cell transplants: From animal disease models to human trials.
Amino Acid Copolymers That Alleviate Experimental Autoimmune Encephalomyelitis In Vivo Interact with Heparan Sulfates and Glycoprotein 96 in APCs.
Mood disorder as the presenting manifestation of demyelination.
Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: Equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome.
Osteopontin in Immune-mediated Diseases.
[Treatment and prognosis of neuromyelitis optica(NMO)].
[Pediatric multiple sclerosis].
Ventricular arrhythmia in a male MS patient on fingolimod.
Systematic review of correlates and determinants of physical activity in persons with multiple sclerosis.
Imaging multiple sclerosis outside the brain.
Evaluation of the Persian version of modified fatigue impact scale in Iranian patients with multiple sclerosis.
Daclizumab, an IL-2 modulating antibody for treatment of multiple sclerosis.
Nogo-Receptor 1 Deficiency Has No Influence on Immune Cell Repertoire or Function during Experimental Autoimmune Encephalomyelitis.
The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity.
Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years.
Lipocalin-2 deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.
Impact of mast cells on multiple sclerosis: inhibitory effect of natalizumab.
Increased levels of brain serotonin correlated with MMP-9 activity and IL-4 levels resulted in severe experimental autoimmune encephalomyelitis (EAE) in obese mice.
Ion-dependent conformational switching by a DNA aptamer that induces remyelination in a mouse model of multiple sclerosis.
MRI and magnetic resonance angiography findings in patients with multiple sclerosis mimicked by stroke.
Pages
« first
‹ previous
…
602
603
604
605
606
607
608
609
610
…
next ›
last »